98%
921
2 minutes
20
Integrating structured clinical knowledge into artificial intelligence (AI) models remains a major challenge. Medical codes primarily reflect administrative workflows rather than clinical reasoning, limiting AI models' ability to capture true clinical relationships and undermining their generalizability. To address this, we introduce , a clinical knowledge graph that integrates eight EHR-based vocabularies, and , a set of 153,166 clinical code embeddings derived from using a graph transformer neural network. provides a machine-readable representation of clinical knowledge that captures semantic relationships among diagnoses, medications, laboratory tests, and procedures. Panels of clinicians from multiple institutions evaluated the embeddings across 96 diseases and more than 3,000 clinical codes, confirming their alignment with expert knowledge. In a retrospective analysis of 4.57 million patients from Clalit Health Services, we show that supports phenotype risk scoring and stratifies individuals by survival outcomes. We further demonstrate that injecting into large language models improves performance on medical question answering, including for region-specific clinical scenarios. enables structured clinical knowledge to be injected into predictive and generative AI models, bridging the gap between EHR codes and clinical reasoning.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11643188 | PMC |
http://dx.doi.org/10.1101/2024.12.03.24318322 | DOI Listing |
Lab Anim Res
September 2025
Korea Model Animal Priority Center (KMPC), Seoul, Republic of Korea.
Background: Laboratory animal veterinarians play a crucial role as a bridge between the ethical use of laboratory animals and the advancement of scientific and medical knowledge in biomedical research. They alleviate pain and reduce distress through veterinary care of laboratory animals. Additionally, they enhance animal welfare by creating environments that mimic natural habitats through environmental enrichment and social associations.
View Article and Find Full Text PDFNeurol Res Pract
September 2025
German Neurological Society, Berlin, Germany.
Background: Recreational nitrous oxide (NO) abuse has become increasingly prevalent, raising concerns about associated health risks. In Germany, the lack of reliable data on NO consumption patterns limits the development of effective public health interventions. This study aims to address this knowledge gap by examining trends, determinants, and health consequences of NO abuse in Germany.
View Article and Find Full Text PDFBMC Public Health
September 2025
Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.
Background: As populations age, more knowledge is needed on people who extend their working lives. The aim of this study was to explore if prior sickness absence (> 14 days) and/or disability pension (SADP) in mental and/or somatic diagnoses were associated with time until work exit after ages 65-69 and ≥ 70, respectively, among women and men.
Methods: This prospective population-based cohort study included all 65-69-year-olds (cohort65, n = 201,263) and ≥ 70-year-olds (cohort70, n = 93,751) who were in paid work in Sweden in 2014.
Res Social Adm Pharm
September 2025
School of Gerontology and Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan; International PhD Program in Gerontology and Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan; Research Center in Nursing Clinical Practice, Wan Fang Hospital, Taipei
Background: Fall risk-increasing drugs (FRIDs) increase the risks of falls, injuries, and fractures among older adults. However, limited evidence exists on how older adults perceive and manage FRID use, particularly in Indonesia.
Objective: This study developed and psychometrically evaluated a questionnaire for assessing knowledge, attitudes, and behaviors (KABs) related to FRID use (hereafter KABQ-FRID) among older adults.
Eur Urol Focus
September 2025
Department of Urology, Medical Centre, University of Heidelberg, Heidelberg, Germany; Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany; Department of Urology, Philipps-University Marburg, Marburg, Germany.
Background And Objective: Since 2016, >21 000 patients with prostate cancer (PC) used our personalized online decision aid in routine care in Germany. We analyzed the effects of this online decision aid for men with nonmetastatic PC in a randomized controlled trial.
Methods: In the randomized controlled EvEnt-PCA trial, 116 centers performed 1:1 allocation of 1115 patients with nonmetastatic PC to use an online decision aid (intervention = I) or a printed brochure (control = C).